PRECICE Stryde
PRECICE Stryde Weight-Bearing Nail
A heavier-duty PRECICE variant allowing full weight-bearing during distraction — recalled in 2021.
How it works
The Stryde nail was designed to allow full weight-bearing during the distraction phase, shortening total recovery time. NuVasive initiated a voluntary field-safety action on February 20, 2021, and the FDA classified it as a Class I recall on April 9, 2021, after reports of corrosion at the telescoping junction and associated bone changes (osteolysis) documented in peer-reviewed series. The device was withdrawn from the US market. Some clinics outside the US continued to offer Stryde afterward; patients considering Stryde today should discuss the recall history and long-term monitoring with their surgeon.
Schematic. Bone geometry and hardware placement are illustrative; consult your surgeon for procedure specifics.
At a glance
- Typical gain
- 5–8 cm
- Total recovery
- 10–18 weeks
- Distraction sites
- femur, tibia
- External hardware
- No
- Manufacturer
- NuVasive Specialized Orthopedics — discontinued; FDA Class I recall April 9, 2021
- Status
- Historical / recalled
What this means for a patient
- ●Full weight-bearing during distraction (historically)
- ●Faster functional recovery vs. PRECICE 2 (historically)
Trade-offs and risks
- ●FDA Class I recall (2021) due to corrosion concerns
- ●Not available in the US
- ●Long-term safety data limited
This page is editorial reporting, not medical advice. Every patient anatomy is different — technique selection requires in-person consultation with a qualified surgeon.